Differential Ability of Cytostatics From Anthraquinone Group to Generate Free Radicals in Three Enzymatic Systems: NADH Dehydrogenase, NADPH Cytochrome P450 Reductase, and Xanthine Oxidase-Reference-Cited by-同舟云学术

Differential Ability of Cytostatics From Anthraquinone Group to Generate Free Radicals in Three Enzymatic Systems: NADH Dehydrogenase, NADPH Cytochrome P450 Reductase, and Xanthine Oxidase

Published:2003-01-01 Issue:5 Volume:13 Page:245-252
ISSN:0965-0407
Container-title:Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
language:en
Short-container-title:oncol res

Author:

Pawłowska Jolanta¹,Tarasiuk Jolanta¹,Wolf C. Roland²,Paine Mark J. I.²,Borowski Edward¹

Affiliation:

1. *Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdansk, Narutowicza St 11/12, 80-952 Gdansk, Poland

2. †Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee, UK

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of silver nanoparticles’ size on their direct interactions with doxorubicin and its biological effects;Scientific Reports;2024-08-09

2. Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation;Expert Opinion on Drug Delivery;2024-03-03

3. Comparative In Vitro Study of the Cytotoxic Effects of Doxorubicin’s Main Metabolites on Cardiac AC16 Cells Versus the Parent Drug;Cardiovascular Toxicology;2024-02-13

4. Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity;Nanoscale;2024

5. Design of carrageenan based nanocarrier as a drug nanocarrier for tumor targeting: Radiolabeling and biodistribution;Journal of Drug Delivery Science and Technology;2023-08